|Day Low/High||1.05 / 1.15|
|52 Wk Low/High||0.00 / 6.80|
This sector is brightening into the holidays, and these names should benefit.
BioDelivery Sciences, Progenics Pharma and Sequential Brands are off-the-radar small-caps poised for a big year in 2017.
The environment for retail should continue to improve as we head into a seasonally strong part of the year.
Doing some incremental buying in names hit by the selloff with little U.K. exposure.
Updates on smaller housing, retail and biotech plays recently mentioned on these pages.
Shopping malls may be struggling, but Martha Stewart's brand is still flying off the shelves.
U.S. stocks are approaching oversold levels for the first time in over a month, prompting our model portfolio to increase its position in Kratos Defense & Security.
Wal-Mart's profits went down more than 10% after a $1-an-hour wage boost.
Investing in small-cap names take a lot of research and patience, but they can also be very rewarding.
I like cheap smaller caps with little to no exposure to the global economy.
Foot Locker and Sequential Brands are well positioned to weather global volatility.
It's a day of near deals after Anthem (ANTM) made a second, higher offer to Cigna (CI) worth $184 a share or $54 billion.
U.S. stocks opened higher Monday on hopes of a Greek deal.
The market has defied premarket futures and opened lower. Some early movers that have caught my eye in early trading include: Highly volatile biotech Tekmira Pharmaceuticals Corp (TKMR). Tekmira is getting hit a bit today, but not as bad as it was t...
Sequential Brands (SQBG) and Martha Stewart Living Omnimedia (MSO) rocketed higher by late afternoon Thursday.
Forecasts of a boost in consumption due to cheap oil were wrong.
Recent activity has heated up and is creating shareholder value.